Table 1.
Baseline characteristics of the study population
| Variables | GI cancer survivors (N = 262) |
Controls (N = 1,310) |
P value |
|---|---|---|---|
| Age (yr) | 67.1 ± 8.7 | 67.1 ± 8.7 | 0.957 |
| Sex | 1.000 | ||
| Male | 155 (59.2%) | 775 (59.2%) | |
| Female | 107 (40.8%) | 535 (40.8%) | |
| Cancer type | |||
| Gastric cancer (male/female) | 158 (94/64) | - | - |
| Colorectal cancer (male/female) | 105 (61/44) | - | - |
| BMI (Kg/m2) | 23.0 ± 3.2 | 24.2 ± 3.1 | < 0.001 |
| Current smoking | 30 (11.5%) | 232 (17.8%) | 0.017 |
| Residence | 0.386 | ||
| Urban | 89 (34.0%) | 485 (37.0%) | |
| Rural | 173 (66.0%) | 825 (63.0%) | |
| Systolic BP | 125.8 ± 17.3 | 126.0 ± 16.6 | 0.915 |
| Diastolic BP | 74.6 ± 10.2 | 74.7 ± 9.9 | 0.753 |
| Hypertension | 92 (35.1%) | 591 (45.1%) | 0.004 |
| Diabetes | 55 (21.0%) | 289 (22.1%) | 0.764 |
| Total cholesterol, mg/dL | 186.7 ± 33.6 | 187.2 ± 39.3 | 0.817 |
| HDL cholesterol, mg/dL | 51.7 ± 13.4 | 48.3 ± 11.8 | < 0.001 |
| Sufficient aerobic physical activity | 0.472 | ||
| No | 167 (63.7%) | 801 (61.2%) | |
| Yes | 95 (36.3%) | 509 (38.9%) | |
| Walking (per week) | 0.354 | ||
| None | 49 (18.7%) | 297 (22.7%) | |
| 1–4 days | 98 (37.4%) | 456 (34.9%) | |
| 5–7 days | 115 (43.9%) | 557 (42.5%) | |
| Strength exercise (per week) | 0.863 | ||
| None | 205 (78.2%) | 1,005 (76.7%) | |
| 1–4 days | 31 (11.8%) | 164 (12.5%) | |
| 5–7 days | 26 (9.9%) | 141 (10.8%) | |
| EQ-5D | 0.723 | ||
| 1 | 155 (59.2%) | 762 (58.2%) | |
| 2 | 28 (10.7%) | 145 (11.1%) | |
| 3 | 44 (16.8%) | 208 (15.9%) | |
| 4 | 24 (9.2%) | 111 (8.5%) | |
| 5 | 11 (4.2%) | 84 (6.4%) | |
BMI Body mass index, BP Blood pressure, HDL High-density lipoprotein, EQ-5D Euro QoL Questionnaire 5-Dimensional Classification